0,967  0,004  Antineoplastic (lung cancer)
0,896  0,004  Antineoplastic (cervical cancer)
0,894  0,005  Antineoplastic (breast cancer)
0,887  0,003  Antineoplastic (carcinoma)
0,885  0,004  Antineoplastic (colon cancer)
0,885  0,005  Antineoplastic (colorectal cancer)
0,871  0,002  Topoisomerase II inhibitor
0,871  0,003  Caspase 3 stimulant
0,861  0,004  Prostate cancer treatment
0,859  0,003  Antineoplastic (squamous cell carcinoma)
0,859  0,004  Tubulin antagonist
0,841  0,005  Antileukemic
0,842  0,012  Apoptosis agonist
0,811  0,004  DNA damaging
0,810  0,005  Antineoplastic (non-small cell lung cancer)
0,803  0,005  Antineoplastic (ovarian cancer)
0,798  0,004  Antimitotic
0,789  0,004  Antineoplastic (multiple myeloma)
0,775  0,004  Antineoplastic (glioma)
0,757  0,005  Antineoplastic (melanoma)
0,750  0,004  Antineoplastic (lymphocytic leukemia)
0,731  0,004  Antineoplastic (brain cancer)
0,726  0,004  Antineoplastic (glioblastoma multiforme)
0,722  0,004  Antineoplastic (renal cancer)
0,701  0,007  Cytostatic
0,689  0,003  Carcinogenic, group 1
0,668  0,003  Topoisomerase II alpha inhibitor
0,662  0,003  Antineoplastic (small cell lung cancer)
0,656  0,006  Antipyretic
0,656  0,012  Antineoplastic (solid tumors)
0,642  0,003  Beta tubulin antagonist
0,638  0,003  Alpha tubulin antagonist
0,633  0,005  Genotoxic
0,631  0,005  Antineoplastic (sarcoma)
0,655  0,029  Caspase 9 stimulant
0,628  0,005  Antineoplastic (lymphoma)
0,622  0,003  Topoisomerase I inhibitor
0,615  0,004  DNA intercalator
0,632  0,028  Transcription factor NF kappa B inhibitor
0,546  0,005  Hepatoprotectant
0,526  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,513  0,003  Carcinogenic, group 2A
0,520  0,019  Hepatic disorders treatment
0,531  0,036  CYP3A4 substrate
0,477  0,021  NOS2 expression inhibitor
0,469  0,017  CYP3A4 inhibitor
0,457  0,035  5 Hydroxytryptamine release stimulant
0,420  0,003  Keratolytic
0,413  0,007  Liver fibrosis treatment
0,429  0,025  Chemopreventive
0,439  0,036  Antihypercholesterolemic
0,405  0,005  Antineoplastic (bone cancer)
0,434  0,052  Immunosuppressant
0,429  0,048  CYP2C19 inhibitor
0,392  0,023  Antineoplastic (osteosarcoma)
0,355  0,009  Alkylator
0,371  0,029  Antineoplastic (liver cancer)
0,337  0,011  Neurotrophic factor enhancer
0,367  0,048  Vasodilator, coronary
0,354  0,042  Cytotoxic
0,296  0,003  Topoisomerase II beta inhibitor
0,302  0,029  P-glycoprotein inhibitor
0,364  0,091  15-Lipoxygenase inhibitor
0,274  0,004  Microtubule formation inhibitor
0,304  0,040  Nitric oxide antagonist
0,287  0,025  Antiviral (Herpes)
0,301  0,041  Cyclic AMP phosphodiesterase inhibitor
0,317  0,062  Antineoplastic (pancreatic cancer)
0,242  0,005  Antineoplastic alkaloid
0,298  0,062  Antioxidant
0,291  0,059  Radiosensitizer
0,288  0,058  Sensitization
0,283  0,054  Vasodilator
0,302  0,075  Respiratory analeptic
0,248  0,022  LDLR expression enhancer
0,321  0,097  Ulceration
0,262  0,040  VCAM1 expression inhibitor
0,280  0,059  Proliferative diseases treatment
0,235  0,017  Phobic disorders treatment
0,257  0,045  Abortion inducer
0,252  0,048  Sigma receptor agonist
0,290  0,090  Antineoplastic (endocrine cancer)
0,201  0,008  Postmenopausal disorders treatment
0,311  0,123  TNF expression inhibitor
0,219  0,037  Contraceptive
0,245  0,063  Pyruvate kinase inhibitor
0,265  0,083  CYP2C19 substrate
0,216  0,035  Melanin inhibitor
0,289  0,114  Antineoplastic (non-Hodgkin's lymphoma)
0,263  0,089  CYP1A2 substrate
0,179  0,006  Ornithine decarboxylase inhibitor
0,181  0,010  CDC-like kinase 3 inhibitor
0,274  0,106  ICAM1 expression inhibitor
0,254  0,086  UGT2B4 substrate
0,228  0,067  Antiparkinsonian, rigidity relieving
0,177  0,017  Calcium antagonist
0,213  0,061  Non-steroidal antiinflammatory agent
0,187  0,037  Acetylcholinesterase inhibitor
0,173  0,024  Alpha 2c adrenoreceptor antagonist
0,176  0,042  Antifungal enhancer
0,180  0,048  CDC-like kinase 1 inhibitor
0,207  0,079  Antihypertriglyceridemic
0,143  0,016  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,128  0,004  Endothelin receptor antagonist
0,234  0,115  Analeptic
0,146  0,028  Alpha 2 adrenoreceptor antagonist
0,129  0,014  ATPase (Vacuolar H+) inhibitor
0,203  0,089  Cardiodepressant
0,130  0,017  Antiprotozoal activity enhancer
0,169  0,056  Protein kinase stimulant
0,170  0,057  Antiischemic, cerebral
0,146  0,035  DNA repair enzyme inhibitor
0,231  0,121  12-Lipoxygenase inhibitor
0,193  0,084  Psychostimulant
0,241  0,134  Vasodilator, peripheral
0,171  0,066  UGT2B10 substrate
0,213  0,109  Spasmolytic
0,112  0,011  Protease activated receptor antagonist
0,139  0,043  Contraceptive female
0,139  0,044  Alpha 2b adrenoreceptor antagonist
0,103  0,009  Glutamate (mGluR7) antagonist
0,113  0,023  Phosphodiesterase 11A inhibitor
0,113  0,023  Phosphodiesterase XI inhibitor
0,193  0,104  Free radical scavenger
0,092  0,004  Endothelin B receptor antagonist
0,157  0,071  Cholinergic
0,090  0,005  Endothelin A receptor antagonist
0,213  0,131  CYP2D6 substrate
0,141  0,062  Cyclooxygenase 1 inhibitor
0,239  0,160  Calcium channel activator
0,156  0,080  Prostate disorders treatment
0,123  0,050  Estrogen antagonist
0,157  0,085  Muscle relaxant
0,175  0,103  Pneumotoxic
0,147  0,076  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,246  0,178  Antineoplastic (myeloid leukemia)
0,130  0,067  Cyclooxygenase 3 inhibitor
0,157  0,095  Lipocortins synthesis antagonist
0,089  0,031  Calcium channel L-type blocker
0,199  0,142  Antiischemic
0,074  0,025  Estrogen agonist
0,137  0,088  Adenylate cyclase stimulant
0,089  0,041  Nicotinic alpha4beta2 receptor antagonist
0,117  0,070  Alcohol dehydrogenase substrate
0,184  0,137  Radioprotector
0,132  0,086  Skeletal muscle relaxant
0,068  0,023  Protease activated receptor 1 antagonist
0,129  0,086  UGT2B15 substrate
0,155  0,113  UGT1A1 substrate
0,132  0,094  NOS3 expression enhancer
0,166  0,132  UGT1A6 substrate
0,099  0,067  Estrogen receptor beta antagonist
0,076  0,045  Phosphodiesterase V inhibitor
0,122  0,092  Lipid peroxidase inhibitor
0,143  0,114  ATPase inhibitor
0,113  0,084  Antifungal (Pneumocystis)
0,117  0,089  Erectile dysfunction treatment
0,068  0,041  Dopamine D1 antagonist
0,053  0,027  Factor III inhibitor
0,129  0,103  UGT1A3 substrate
0,113  0,088  Cyclooxygenase 2 inhibitor
0,130  0,107  Prostatic (benign) hyperplasia treatment
0,181  0,159  UGT1A9 substrate
0,156  0,135  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,182  0,161  Transcription factor STAT3 inhibitor
0,091  0,074  UGT2B11 substrate
0,072  0,056  Alpha 2a adrenoreceptor antagonist
0,074  0,059  Antitreponemal
0,129  0,114  Carcinogenic
0,099  0,084  Electron transport complex I inhibitor
0,140  0,126  Embryotoxic
0,128  0,115  Male reproductive disfunction treatment
0,082  0,070  Alpha adrenoreceptor antagonist
0,065  0,056  Phosphodiesterase 5A inhibitor
0,183  0,177  AR expression inhibitor
0,204  0,198  Histamine release inhibitor
0,064  0,059  Transforming growth factor antagonist
0,082  0,077  Breast cancer-resistant protein inhibitor
0,178  0,174  Antineoplastic (bladder cancer)
0,179  0,176  CYP2D6 inhibitor
0,149  0,146  Antiprotozoal (Leishmania)
0,082  0,080  Butyrylcholinesterase inhibitor
0,098  0,095  Acetylcholine antagonist
0,055  0,053  Ryanodine receptor antagonist
0,049  0,047  Alpha 1L adrenoreceptor antagonist
0,066  0,064  Na+ K+ transporting ATPase inhibitor

